Management of locally advanced lynch syndrome rectal cancer during pregnancy with neoadjuvant immunochemotherapy: a case report - Summary - MDSpire

Management of locally advanced lynch syndrome rectal cancer during pregnancy with neoadjuvant immunochemotherapy: a case report

  • By

  • Shaoqing Fan

  • Xiurong Li

  • Li Shi

  • Jianan Dong

  • May 20, 2026

  • 0 min

Share

Objective:

To present a case of locally advanced rectal cancer associated with Lynch syndrome during pregnancy and discuss the management approach, highlighting its significance in the context of existing literature.

Key Findings:
  • The patient had a significant tumor regression (yT2N0M0) after neoadjuvant treatment, indicating the potential effectiveness of this approach.
  • Medical termination of pregnancy was necessary due to fetal viability concerns and potential teratogenic risks, highlighting the ethical complexities involved.
  • The patient experienced limited adverse effects during treatment, all resolving with supportive care, suggesting a manageable treatment profile.
Interpretation:

This case highlights the complexities of managing rectal cancer in pregnant patients with Lynch syndrome, emphasizing the need for individualized, multidisciplinary approaches.

Limitations:
  • The rarity of the condition limits generalizability of findings and may introduce biases in the case study methodology.
  • Limited evidence exists regarding standardized management protocols for colorectal cancer during pregnancy, necessitating further research.
Conclusion:

Individualized management involving medical termination followed by neoadjuvant immunochemoradiotherapy can optimize outcomes for mothers with LS-associated rectal cancer during pregnancy, emphasizing the need for multidisciplinary approaches.

Original Source(s)

Related Content